Biological mechanisms involved in the spread of traumatic brain damage;Mecanismos biológicos involucrados en la propagación del daño en el traumatismo encéfalo craneano

Medicina Intensiva

Volumn 36, Issue 1, 2012, Pages 37-44

  Rovegno, M ^a,b   Soto, P A ^b   Saez J C ^b   von Bernhardi, R ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Apoptosis; Brain injury; Excitotoxicity; Neuroglia; Neuroinflammation; Traumatic brain injury

Indexed keywords

APOPTOSIS; CELL FUNCTION; DISEASE SEVERITY; EXCITOTOXICITY; GLIA CELL; HUMAN; INFLAMMATION; NEUROPROTECTION; PATHOPHYSIOLOGY; PREVALENCE; SHORT SURVEY; TRAUMATIC BRAIN INJURY;

ANIMALS; APOPTOSIS; BRAIN DEATH; BRAIN EDEMA; BRAIN INJURIES; CELL SIZE; DIFFUSE AXONAL INJURY; GLUTAMIC ACID; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INTRACRANIAL HYPERTENSION; ION TRANSPORT; MODELS, NEUROLOGICAL; NEUROGLIA; NEURONS;

EID: 84855832646     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2011.06.008     Document Type: Short Survey

References (72)

1. Langlois J.A., Rutland-Brown W., Wald M.M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006, 21:375-378.
2. Tagliaferri F., Compagnone C., Korsic M., Servadei F., Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien) 2006, 148:255-268.
3. Narayan R.K., Michel M.E., Ansell B., Baethmann A., Biegon A., Bracken M.B., et al. Clinical trials in head injury. J Neurotrauma 2002, 19:503-557.
4. Werner C., Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007, 99:4-9.
5. Adams J.H., Graham D.I., Scott G., Parker L.S., Doyle D. Brain damage in fatal non-missile head injury. J Clin Pathol 1980, 33:1132-1145.
6. Chesnut R.M. Care of central nervous system injuries. Surg Clin North Am 2007, 87:119-156.
7. Dardiotis E., Fountas K.N., Dardioti M., Xiromerisiou G., Kapsalaki E., Tasiou A., et al. Genetic association studies in patients with traumatic brain injury. Neurosurg Focus 2010, 28:E9.
8. Zhou W., Xu D., Peng X., Zhang Q., Jia J., Crutcher K.A. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma 2008, 25:279-290.
9. Martínez-Lucas P., Moreno-Cuesta J., García-Olmo D.C., Sánchez-Sánchez F., Escribano-Martínez J., Pozo A.C.del, et al. Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury. Intensive Care Med 2005, 31:1168-1173.
10. Hadjigeorgiou G.M., Paterakis K., Dardiotis E., Dardioti M., Aggelakis K., Tasiou A., et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. Neurology 2005, 65:1077-1082.
11. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009, 27:119-145.
12. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
13. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8:752-758.
14. Platten M., Kretz A., Naumann U., Aulwurm S., Egashira K., Isenmann S., et al. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 2003, 54:388-392.
15. De Simone R., Ambrosini E., Carnevale D., Ajmone-Cat M.A., Minghetti L. NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-beta. J Neuroimmunol 2007, 190:53-60.
16. Laird M.D., Vender J.R., Dhandapani K.M. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 2008, 16:154-164.
17. Wieloch T., Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 2006, 16:258-264.
18. Morganti-Kossmann M.C., Satgunaseelan L., Bye N., Kossmann T. Modulation of immune response by head injury. Injury 2007, 38:1392-1400.
19. Hayakata T., Shiozaki T., Tasaki O., Ikegawa H., Inoue Y., Toshiyuki F., et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004, 22:102-107.
20. Kossmann T., Hans V., Imhof H.G., Trentz O., Morganti-Kossmann M.C. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain ResV 713 1996, 143-152.
21. Edwards P., Arango M., Balica L., Cottingham R., El-Sayed H., Farrell B., et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005, 365:1957-1959.
22. Clausen F., Hånell A., Björk M., Hillered L., Mir A.K., Gram H., et al. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci 2009, 30:385-396.
23. Frantseva M.V., Kokarovtseva L., Naus C.G., Carlen P.L., MacFabe D., Perez Velazquez J.L. Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J Neuroscience 2002, 22:644-653.
24. Raghupathi R., Conti A.C., Graham D.I., Krajewski S., Reed J.C., Grady M.S., et al. Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity. Neuroscience 2002, 110:605-616.
25. Clark R.S., Kochanek P.M., Chen M., Watkins S.C., Marion D.W., Chen J., et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 1999, 13:813-821.
26. Miñambres E., Ballesteros M.A., Mayorga M., Marin M.J., Muñoz P., Figols J., et al. Cerebral apoptosis in severe traumatic brain injury patients: an in vitro, in vivo, and postmortem study. J Neurotrauma 2008, 25:581-591.
27. Clark R.S., Kochanek P.M., Watkins S.C., Chen M., Dixon C.E., Seidberg N.A., et al. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem 2000, 74:740-753.
28. Scheff S.W., Sullivan P.G., Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J Neurotrauma 1999, 16:783-792.
29. Sullivan P.G., Rabchevsky A.G., Hicks R.R., Gibson T.R., Fletcher-Turner A., Scheff S.W. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 2000, 101:289-295.
30. Hansson M.J., Persson T., Friberg H., Keep M.F., Rees A., Wieloch T., et al. Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 2003, 960:99-111.
31. Uchino H., Elmér E., Uchino K., Li P.A., He Q.P., Smith M.L., et al. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Res 1998, 812:216-226.
32. Sullivan P.G., Thompson M.B., Scheff S.W. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 1999, 160:226-234.
33. Mbye L.H., Singh I.N., Carrico K.M., Saatman K.E., Hall E.D. Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J Cereb Blood Flow Metab 2009, 29:87-97.
34. Miller J.D., Becker D.P., Ward J.D., Sullivan H.G., Adams W.E., Rosner M.J. Significance of intracranial hypertension in severe head injury. J Neurosurg 1977, 47:503-516.
35. Klatzo I. Presidental address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol 1967, 26:1-14.
36. Marmarou A., Signoretti S., Fatouros P.P., Portella G., Aygok G.A., Bullock M.R. Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries. J Neurosurg 2006, 104:720-730.
37. Barron K.D., Dentinger M.P., Kimelberg H.K., Nelson L.R., Bourke R.S., Keegan S., et al. Ultrastructural features of a brain injury model in cat. I. Vascular and neuroglial changes and the prevention of astroglial swelling by a fluorenyl (aryloxy) alkanoic acid derivative (L-644,711). Acta Neuropathol 1988, 75:295-307.
38. Oberheim N.A., Wang X., Goldman S., Nedergaard M. Astrocytic complexity distinguishes the human brain. Trends Neurosci 2006, 29:547-553.
39. Unterberg A.W., Stover J., Kress B., Kiening K.L. Edema and brain trauma. Neuroscience 2004, 129:1021-1029.
40. Rash J.E., Yasumura T., Hudson C.S., Agre P., Nielsen S. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci USA 1998, 95:11981-11986.
41. Manley G.T., Fujimura M., Ma T., Noshita N., Filiz F., Bollen A.W., et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000, 6:159-163.
42. Yukutake Y., Hirano Y., Suematsu M., Yasui M. Rapid and reversible inhibition of aquaporin-4 by zinc. Biochemistry 2009, 48:12059-12061.
43. Kikuchi K., Tancharoen S., Matsuda F., Biswas K.K., Ito T., Morimoto Y., et al. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4. Biochem Biophys Res Commun 2009, 390:1121-1125.
44. Palmer A.M., Marion D.W., Botscheller M.L., Swedlow P.E., Styren S.D., DeKosky S.T. Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 1993, 61:2015-2024.
45. Bullock R., Zauner a, Woodward J.J., Myseros J., Choi S.C., Ward J.D., et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 1998, 89:507-518.
46. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001, 69:369-381.
47. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003, 4:552-565.
48. Bruzzone R., Giaume C. Connexins and information transfer through glia. Adv Exp Med Biol 1999, 468:321-337.
49. Rao V.L., Başkaya M.K., Doĝan A., Rothstein J.D., Dempsey R.J. Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J Neurochem 1998, 70:2020-2027.
50. Allen N.J., Káradóttir R., Attwell D. Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy. Pflügers Archiv 2004, 449:132-142.
51. Lucas D.R., Newhouse J.P. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 1957, 58:193-201.
52. Jain K.K. Neuroprotection in traumatic brain injury. Drug Discov Today 2008, 13:1082-1089.
53. Morris G.F., Bullock R., Marshall S.B., Marmarou A., Maas A., Marshall L.F. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg 1999, 91:737-743.
54. Temkin N.R., Anderson G.D., Winn H.R., Ellenbogen R.G., Britz G.W., Schuster J., et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 2007, 6:29-38.
55. Giaume C., Kirchhoff F., Matute C., Reichenbach A., Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ 2007, 14:1324-1335.
56. Bezzi P., Volterra A. A neuron-glia signalling network in the active brain. Curr Opin Neurobiol 2001, 11:387-394.
57. Floyd C.L., Lyeth B.G. Astroglia: important mediators of traumatic brain injury. Prog Brain Res 2007, 161:61-79.
58. Kang J., Kang N., Lovatt D., Torres A., Zhao Z., Lin J., et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci 2008, 28:4702-4711.
59. Lin J.H., Weigel H., Cotrina M.L., Liu S., Bueno E., Hansen A.J., et al. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1998, 1:494-500.
60. Cusato K., Bosco A., Rozental R., Guimarães C.A., Reese B.E., Linden R., et al. Gap junctions mediate bystander cell death in developing retina. J Neurosci 2003, 23:6413-6422.
61. Sáez J.C., Contreras J.E., Bukauskas F.F., Retamal M.A., Bennett M.V.L. Gap junction hemichannels in astrocytes of the CNS. Acta Physiol Scand 2003, 179:9-22.
62. Decrock E., De Vuyst E., Vinken M., Van Moorhem M., Vranckx K., Wang N., et al. Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death Differ 2009, 16:151-163.
63. Contreras J.E., Sánchez H.A., Eugenin E.A., Speidel D., Theis M., Willecke K., et al. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci USA 2002, 99:495-500.
64. Bahima L., Aleu J., Elias M., Martín-Satué M., Muhaisen A., Blasi J., et al. Endogenous hemichannels play a role in the release of ATP from Xenopus oocytes. J Cell Physiol 2006, 206:95-102.
65. Srinivas M., Calderon D.P., Kronengold J., Verselis V.K. Regulation of connexin hemichannels by monovalent cations. J Gen Physiol 2006, 127:67-75.
66. Nilsson P., Hillered L., Olsson Y., Sheardown M.J., Hansen A.J. Regional changes in interstitial K+ and Ca2+ levels following cortical compression contusion trauma in rats. J Cereb Blood Flow Metab 1993, 13:183-192.
67. Duffy S., MacVicar B.A. Potassium-dependent calcium influx in acutely isolated hippocampal astrocytes. Neuroscience 1994, 61:51-61.
68. Sánchez H.A., Orellana J.A., Verselis V.K., Sáez J.C. Metabolic inhibition increases activity of connexin-32 hemichannels permeable to Ca2+ in transfected HeLa cells. Am J Physiol Cell Physiol 2009, 297:C665-C678.
69. Arai K., Lo E.H. Oligovascular signaling in white matter stroke. Biol Pharm Bull 2009, 32:1639-1644.
70. Niess C., Grauel U., Toennes S.W., Bratzke H. Incidence of axonal injury in human brain tissue. Acta Neuropathol 2002, 104:79-84.
71. Smith D.H., Meaney D.F. Axonal Damage in Traumatic Brain Injury. Neuroscientist 2000, 6:483-495.
72. Farkas O., Povlishock J.T. Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res 2007, 161:43-59.